Discuss This Drug

anagrelide

CHEBI:CHEBI_142290

Definition

A 1,5-dihydroimidazo[2,1-]quinazoline having an oxo substituent at the 2-position and chloro substituents at the 6- and 7-positions.

Chemical Information

Molecular Formula
C10H7Cl2N3O
Molecular Mass
256.08800
Charge
0
SMILES
Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl
InChI
InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)
InChIKey
OTBXOEAOVRKTNQ-UHFFFAOYSA-N

Alternative Names

  • 6,7-dichloro-1,5-dihydroimidazo[2,1-]quinazolin-2(3H)-one
  • anagrelida
  • anagrelide
  • anagrelidum

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
596724
oboInOwl#hasDbXref
Wikipedia:Anagrelide
core#notation
CHEBI:142290

Additional References

Wikipedia:Anagrelide

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
596724
generic_name
Anagrelide
brand_name
Anagrelide
brand_name_base
Anagrelide
oboInOwl#hasDbXref
Wikipedia:Anagrelide
oboInOwl#id
CHEBI:142290
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
route
ORAL
dosage_form
CAPSULE
marketing_start_date
20050418
labeler_name
Chartwell RX, LLC
product_ndc
62135-313
spl_id
a049d02a-22e1-4ea2-8c05-50b50cef4362
package_ndc
62135-313-60
package_description
60 CAPSULE in 1 BOTTLE (62135-313-60)
application_number
ANDA209151
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_50427
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
core#notation
CHEBI:142290
rxcui
597857
active_ingredient_strength
3 kg/3kg
package_marketing_start_date
18-SEP-24
pharm_class
Platelet-reducing Agent [EPC]
manufacturer_name
Chartwell RX, LLC
active_ingredient_name
ANAGRELIDE HYDROCHLORIDE ANHYDROUS
unii
VNS4435G39
spl_set_id
875cc32a-219c-4b6b-802a-98a47cbc9a78
upc
0313668462302
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
has_treatment
http://purl.obolibrary.org/obo/DOID_9240
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect5250
owl#annotatedSource
t112538
owl#someValuesFrom
t962066